Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
Status:
Completed
Trial end date:
2011-04-13
Target enrollment:
Participant gender:
Summary
This study will use imaging to look at tumor response to combination chemotherapy of
gemcitabine (Gem) and cisplatin (Cis) or gemcitabine and carboplatin (Carbo) in non small
cell lung cancer (NSCLC).